MAP2K7 and glioblastoma: Taken together, our analysis reveals NF1-mutant MES-like glioblastoma tumor cells harbor a distinct molecular signature associated with Ras/RAF/MEK activation compared with either non-MES cells or NF1 wild-type glioblastomas.